Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease

PLoS One. 2017 Apr 17;12(4):e0175649. doi: 10.1371/journal.pone.0175649. eCollection 2017.

Abstract

Background: The genetic architecture of coronary artery disease has not been fully elucidated, especially in Asian countries. Moyamoya disease is a progressive cerebrovascular disease that is reported to be complicated by coronary artery disease. Because most Japanese patients with moyamoya disease carry the p.R4810K variant of the ring finger 213 gene (RNF213), this may also be a risk factor for coronary artery disease; however, this possibility has never been tested.

Methods and results: We genotyped the RNF213 p.R4810K variant in 956 coronary artery disease patients and 716 controls and tested the association between p.R4810K and coronary artery disease. We also validated the association in an independent population of 311 coronary artery disease patients and 494 controls. In the replication study, the p.R4810K genotypes were imputed from genome-wide genotyping data based on the 1000 Genomes Project. We used multivariate logistic regression analyses to adjust for well-known risk factors such as dyslipidemia and smoking habits. In the primary study population, the frequency of the minor variant allele was significantly higher in patients with coronary artery disease than in controls (2.04% vs. 0.98%), with an odds ratio of 2.11 (p = 0.017). Under a dominant model, after adjustment for risk factors, the association remained significant, with an odds ratio of 2.90 (95% confidence interval: 1.37-6.61; p = 0.005). In the replication study, the association was significant after adjustment for age and sex (odds ratio = 4.99; 95% confidence interval: 1.16-21.53; p = 0.031), although it did not reach statistical significance when further adjusted for risk factors (odds ratio = 3.82; 95% confidence interval: 0.87-16.77; p = 0.076).

Conclusions: The RNF213 p.R4810K variant appears to be significantly associated with coronary artery disease in the Japanese population.

MeSH terms

  • Adenosine Triphosphatases / genetics*
  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution
  • Asian People / genetics
  • Case-Control Studies
  • Coronary Artery Disease / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Moyamoya Disease / genetics*
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Ubiquitin-Protein Ligases / genetics*

Substances

  • RNF213 protein, human
  • Ubiquitin-Protein Ligases
  • Adenosine Triphosphatases

Grants and funding

The primary study was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, including those for Scientific Research (A) to AK (25253047), Scientific Research (B) to KO (26293186), and Young Scientists (B) to YM (15K19963) and HK (15K19243), and grants from the St. Luke Life Science Institute to YM, the Shimizu Foundation for Immunology and Neuroscience to YM, the Japan Brain Foundation to YM, and the Fujiwara Foundation of Science to YM. The replication study was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, including those for Scientific Research (B) to MY (24390169, 16H05250), Scientific Research (C) to KY (15K08290), and Scientific Research on Innovative Areas to MN (16H06277), and grant from the Suzuken Memorial Foundation to MY (14-003).